
Embla Medical hf. (OSSFF)
OSSFF Stock Price Chart
Explore Embla Medical hf. interactive price chart. Choose custom timeframes to analyze OSSFF price movements and trends.
OSSFF Company Profile
Discover essential business fundamentals and corporate details for Embla Medical hf. (OSSFF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
23 May 2019
Employees
4.00K
Website
https://www.emblamedical.comCEO
Sveinn Solvason
Description
Embla Medical hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. It operates through the following geographical segments: Americas; Europe Middle-East and Africa; and Americas and Aisa-Pacific. The company was founded by Össur Kristinsson in 1971 and is headquartered in Reykjavík, Iceland.
OSSFF Financial Timeline
Browse a chronological timeline of Embla Medical hf. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 22 Oct 2025
Revenue estimate is $234.95M.
Earnings released on 22 Jul 2025
EPS came in at $0.05 surpassing the estimated $0.05 by +0.50%, while revenue for the quarter reached $232.42M , missing expectations by -0.85%.
Earnings released on 29 Apr 2025
EPS came in at $0.03 falling short of the estimated $0.04 by -19.52%, while revenue for the quarter reached $208.27M , missing expectations by -8.61%.
Earnings released on 5 Feb 2025
EPS came in at $0.04 falling short of the estimated $0.05 by -9.28%, while revenue for the quarter reached $224.78M , missing expectations by -0.56%.
Earnings released on 22 Oct 2024
EPS came in at $0.05 surpassing the estimated $0.04 by +23.40%, while revenue for the quarter reached $213.53M , beating expectations by +0.64%.
Earnings released on 23 Jul 2024
EPS came in at $0.05 surpassing the estimated $0.05 by +1.50%, while revenue for the quarter reached $215.20M , missing expectations by -2.65%.
Earnings released on 23 Apr 2024
EPS came in at $0.02 falling short of the estimated $0.03 by -26.92%, while revenue for the quarter reached $199.85M , beating expectations by +1.27%.
Earnings released on 13 Mar 2024
EPS came in at $0.05 surpassing the estimated $0.04 by +5.91%, while revenue for the quarter reached $210.20M , beating expectations by +1.15%.
Earnings released on 30 Sept 2023
EPS came in at $0.03 surpassing the estimated $0.02 by +33.58%, while revenue for the quarter reached $192.92M , missing expectations by -2.05%.
Earnings released on 30 Jun 2023
EPS came in at $0.04 surpassing the estimated $0.03 by +10.44%, while revenue for the quarter reached $201.35M , beating expectations by +1.36%.
Earnings released on 31 Mar 2023
EPS came in at $0.02 falling short of the estimated $0.03 by -11.08%, while revenue for the quarter reached $181.21M , missing expectations by -0.21%.
Earnings released on 31 Jan 2023
EPS came in at $0.03 falling short of the estimated $0.04 by -25.00%, while revenue for the quarter reached $190.94M , missing expectations by -1.35%.
Earnings released on 25 Oct 2022
EPS came in at $0.02 falling short of the estimated $0.03 by -20.00%, while revenue for the quarter reached $176.70M , missing expectations by -3.27%.
Earnings released on 21 Jul 2022
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $180.95M , missing expectations by -5.99%.
Earnings released on 26 Apr 2022
EPS came in at $0.02 matching the estimated $0.02, while revenue for the quarter reached $170.06M , missing expectations by -2.06%.
Earnings released on 1 Feb 2022
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $187.54M , missing expectations by -1.05%.
Earnings released on 26 Oct 2021
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $180.29M .
Earnings released on 22 Jul 2021
EPS came in at $0.05 matching the estimated $0.05, while revenue for the quarter reached $189.99M .
Earnings released on 27 Apr 2021
EPS came in at $0.03 surpassing the estimated $0.02 by +50.00%, while revenue for the quarter reached $160.85M .
Earnings released on 2 Feb 2021
EPS came in at $0.01 falling short of the estimated $0.03 by -69.70%, while revenue for the quarter reached $169.57M .
Earnings released on 27 Oct 2020
EPS came in at $0.03 matching the estimated $0.03, while revenue for the quarter reached $171.79M .
OSSFF Stock Performance
Access detailed OSSFF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.